Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

From left ventricular dysfunction to heart failure

J G Cleland1

  • 1University of Glasgow, Scotland, UK.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease.

Pharmacological research·2022
Same author

The association between blood groups and COVID-19 infection: a study from the UK Biobank.

Journal of internal medicine·2020
Same author

Tumour biomarkers: association with heart failure outcomes.

Journal of internal medicine·2020
Same author

Added value of frailty and social support in predicting risk of 30-day unplanned re-admission or death for patients with heart failure: An analysis from OPERA-HF.

International journal of cardiology·2018
Same author

Novel endotypes in heart failure: effects on guideline-directed medical therapy.

European heart journal·2018
Same author

Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study.

European heart journal·2017
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

The link between ventricular dysfunction and heart failure is complex. While some patients develop heart failure after myocardial infarction, others with left ventricular dysfunction die before progression, highlighting varied disease pathways.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Ventricular dysfunction and heart failure share a complex interrelationship.
  • Many patients with left ventricular dysfunction do not progress to heart failure, often succumbing to other causes.
  • A significant subset of patients develop heart failure rapidly post-myocardial infarction, bypassing chronic ventricular dysfunction.

Purpose of the Study:

  • To elucidate the complex relationship between ventricular dysfunction and heart failure progression.
  • To identify key mechanisms contributing to heart failure development and progression.
  • To evaluate the impact of specific pharmacological interventions on heart failure progression.

Main Methods:

  • Review of existing literature on ventricular dysfunction and heart failure.

Related Experiment Videos

  • Analysis of patient pathways from myocardial infarction to heart failure.
  • Examination of the roles of atrial fibrillation, myocardial ischemia/infarction, and left ventricular remodeling.
  • Assessment of the effects of ACE inhibitors, beta-blockers, diuretics, and digoxin on heart failure progression.

    • Main Results:

    • Left ventricular dysfunction does not always precede heart failure; acute events like myocardial infarction can lead to rapid heart failure onset.
    • Mechanisms such as atrial fibrillation, myocardial ischemia/infarction, and left ventricular remodeling are crucial in heart failure progression.
    • ACE inhibitors and beta-blockers show potential in altering heart failure progression, unlike diuretics or digoxin.
    • Aspirin's potential adverse effects on prognosis in heart failure patients with coronary artery disease warrant significant concern.

    Conclusions:

    • The progression to heart failure is multifactorial and not solely dependent on chronic left ventricular dysfunction.
    • Pharmacological interventions like ACE inhibitors and beta-blockers may play a role in managing heart failure progression.
    • Further investigation into aspirin's role in heart failure patients with coronary artery disease is critical.